<p>Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.</p>

Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.

Share Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Sign up to save your podcasts

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition

More shows like Prostate Cancer Update

Breast Cancer Update

Lung Cancer Update

Hematologic Oncology Update

Gastrointestinal Cancer Update

The Rich Roll Podcast

Gynecologic Oncology Update

Dermatologic Oncology Update

Research To Practice | Oncology Videos

The Daily

Up First from NPR

The Uromigos

GU Cast | Urology Podcast

Oncology Today with Dr Neil Love

Two Onc Docs

Prostate Cancer: The Road to Recovery

PROSTATE CANCER: REAL TALK™

Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing